GlobalData on MSN1mon
TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2DTheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin), a type 2 diabetes (T2D) ...
TheracosBio and BAMCO Africa, Inc. today announced they have partnered to bring BRENZAVVY® (bexagliflozin), an FDA-approved oral sodium-glucose cotransporter 2 (SGLT2) inhibitor for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback